Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Should You Buy Novocure Stock Right Now?


Going, going, gone? That could be the question that (NASDAQ: NVCR) investors are asking these days. Shares of the oncology company plunged 56% in 2021. The stock slid 2% lower last year. And so far in 2023, Novocure is down around 13%.

However, some would argue that the best days for the company lie ahead. Should you buy Novocure stock right now? Here are the cases both for and against this beaten-down cancer stock.

Let's start with the pessimistic view. When a stock falls as much as Novocure has over the last couple of years or so, there's always an underlying reason.

Continue reading


Source Fool.com

Novocure Ltd Aktie

21,05 €
0,46 %
Leichte Gewinne bei Novocure Ltd heute, der Kurs steigt um 0,46 %.

Like: 0
Teilen

Kommentare